Safety assessment of AGPC as a food ingredient

Food and Chemical Toxicology

Volumn 49, Issue 6, 2011, Pages 1303-1315

  Brownawell, Amy M ^a   Carmines, Edward L ^b   Montesano, Federica ^c  

^a Life Sciences Research Organization   (United States)

^b Carmines Consulting LLC   (United States)

^c Chemi SpA   (Italy)

Author keywords

Glycerylphosphorylcholine; Mutagenicity; Oral; Safety; Toxicity

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; CHOLINE ALFOSCERATE; TRIACYLGLYCEROL;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; CONVULSION; EXPERIMENTAL DOG; FEMALE; FOOD COMPOSITION; FOOD SAFETY; GENE CONVERSION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LD 50; LIVER WEIGHT; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGEN TESTING; NONHUMAN; RAT; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; BILIRUBIN; DNA; DOGS; EATING; FEMALE; FOOD ADDITIVES; FOOD SAFETY; GLYCERYLPHOSPHORYLCHOLINE; LETHAL DOSE 50; LIVER; MALE; MICE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS; TRIGLYCERIDES; WEIGHT GAIN;

ANIMALIA; CANIS FAMILIARIS; MUS; RATTUS;

EID: 79955664779     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2011.03.012     Document Type: Article

References (37)

1. Abbiati G., Fossati T., Arrigoni M., Rolle P., Dognini G.L., Castiglioni C. High-performance liquid chromatographic assay of L-α-glycerophosphorylcholine using a two-step enzymic conversion. J. Chromatogr. B: Biomed. Sci. and Appl. 1991, 566:445-451.
2. 14C]-L-α-glycerylphosphorylcholine. Eur. J. Drug Metab. Pharmacokinet. 1993, 18:173-180.
3. Amenta F., Parnetti L., Gallai V., Wallin A. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?. Mech. Ageing Dev. 2001, 122:2025-2040.
4. Ban, T.A., Panzarasa, R.M., Borra, S., Del Duchetto, D., Fjetland, O., 1991. Choline alphoscerate in elderly patients with cognitive decline due to dementing illness. New Trends Clin. Neuropharmacol. V, 1-33.
5. Barbagallo Sangiorgi G., Barbagallo M., Giordano M., Meli M., Panzarasa R. Alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Ann. N. Y. Acad. Sci. 1994, 717:253-269.
6. Bliss C.I. The calculation of microbial assays. Bacteriol. Rev. 1956, 20:243-258.
7. CFSAN/FDA, 2004. Agency Response Letter GRAS Notice No. GRN 000134. Available at Accessed 4-16-2010. http://www.fda.gov/Food/FoodIngredientsPackaging.
8. CFSAN/FDA, 2008. Agency Response Letter GRAS Notice No. GRN 000226. Available at Accessed 4-16-2010. http://www.fda.gov.
9. Cho H.J., Kim Y.J. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4, 191 cases. Methods Find. Exp. Clin. Pharmacol. 2009, 31:171-176.
10. De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. Clin. Ther. 2003, 25:178-193.
11. Drago F., Mauceri F., Nardo L., Valerio C., Genazzani A., Grassi M. Effects of cytidine-diphosphocholine on acetylcholine-mediated behaviors in the rat. Brain Res. Bull. 1993, 31:485-489.
12. Drago F., Mauceri F., Nardo L., Valerio C., Lauria N., Rampello L., Guidi G. Behavioral effects of L-alpha-glycerylphosphorylcholine: Influence on cognitive mechanisms in the rat. Pharmacol. Biochem. Behav. 1992, 41:445-448.
13. Evaluation of the Health Aspects of Choline Chloride and Choline Bitartrate as Food Ingredients 1975, Federation of American Societies for Experimental Biology, FASEB, Bethesda, MD.
14. Ferraro L., Tanganelli S., Marani L., Bianchi C., Beani L., Siniscalchi A. Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by alpha-glycerylphosphorylcholine. Neurochem. Res. 1996, 21:547-552.
15. Fischer L.M., Scearce J.A., Mar M.H., Patel J.R., Blanchard R.T., Macintosh B.A., Busby M.G., Zeisel S.H. Ad libitum choline intake in healthy individuals meets or exceeds the proposed adequate intake level. J. Nutr. 2005, 135:826-829.
16. Gatti G., Barzaghi N., Acuto G., Abbiati G., Fossati T., Perucca E. A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 1992, 30:331-335.
17. Holmes H.C., Snodgrass G.J., Iles R.A. Changes in the choline content of human breast milk in the first 3weeks after birth. Eur. J. Pediatr. 2000, 159:198-204.
18. Holmes-McNary M.Q., Cheng W.L., Mar M.H., Fussell S., Zeisel S.H. Choline and choline esters in human and rat milk and in infant formulas. Am. J. Clin. Nutr. 1996, 64:572-576.
19. Ilcol Y.O., Ozbek R., Hamurtekin E., Ulus I.H. Choline status in newborns, infants, children, breast-feeding women, breast-fed infants and human breast milk. J. Nutr. Biochem. 2005, 16:489-499.
20. 12, Pantothenic Acid, Biotin and Choline 1998, Institute of Medicine, National Academies Press, Washington, DC, pp. 390-422.
21. Evaluation of the Health Aspects of Lecithin as a Food Ingredient. SCOGS-106 1979, Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, MD.
22. Lopez C.M., Govoni S., Battaini F., Bergamaschi S., Longoni A., Giaroni C., Trabucchi M. Effect of a new cognition enhancer, alpha-glycerylphosphorylcholine, on scopolamine-induced amnesia and brain acetylcholine. Pharmacol. Biochem. Behav. 1991, 39:835-840.
23. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
24. OECD Guidelines for the Testing of Chemicals 2009, Organisation for Economic Co-operation, Development, OECD, Paris.
25. Parnetti L., Abate G., Bartorelli L., Cucinotta D., Cuzzupoli M., Maggioni M., Villardita C., Senin U. Multicentre study of l-α-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type. Drugs Aging 1993, 3:159-164.
26. Parnetti L., Amenta F., Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: An analysis of published clinical data. Mech. Ageing Dev. 2001, 122:2041-2055.
27. Patterson, K.Y., Bhagwat, S.A., Williams, J.R., Howe, J.C., Holden, J.M., 2008. USDA Database for the Choline Content of Common Foods - Release Two. http://www.ars.usda.gov.
28. Schauss A.G., Somfai-Relle S., Financsek I., Glavits R., Parent S.C., Endres J.R., Varga T., Szucs Z., Clewell A. Single- and repeated-dose oral toxicity studies of citicoline free-base (choline cytidine 5'-pyrophosphate) in Sprague-Dawley rats. Int. J. Toxicol. 2009, 28:479-487.
29. Schettini G., Ventra C., Florio T., Grimaldi M., Meucci O., Scorziello A., Postiglione A., Marino A. Molecular mechanisms mediating the effects of L-α-glycerylphosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged rats. Pharmacol. Biochem. Behav. 1992, 43:139-151.
30. Secades J.J., Lorenzo J.L. Citicoline: Pharmacological and clinical review, 2006 update. Methods Find. Exp. Clin. Pharmacol. 2006, 28(Suppl B):1-56.
31. Sigala S., Imperato A., Rizzonelli P., Casolini P., Missale C., Spano P. L-α-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Eur. J. Pharmacol. 1992, 211:351-358.
32. Trabucchi M., Govoni S., Battaini F. Changes in the interaction between CNS cholinergic and dopaminergic neurons induced by L-α-glycerylphosphorylcholine, a cholinomimetic drug. Farmaco Sci. 1986, 41:325-334.
33. US Code of Federal Regulations, 2006. CFR 21 § 184.1400 Lecithin. Available at Accessed 8-3-2010. http://www.edocket.access.gpo.gov.
34. US Code of Federal Regulations, 2010. Part 182 Substances generally recognized as safe. Sec. 182.8252 Choline chloride.
35. Zeisel S.H. Dietary choline: Biochemistry, physiology, and pharmacology. Annu. Rev. Nutr. 1981, 1:95-121.
36. Zeisel S.H., Da Costa K.A., Franklin P.D., Alexander E.A., Lamont J.T., Sheard N.F., Beiser A. Choline, an essential nutrient for humans. FASEB J. 1991, 5:2093-2098.
37. Ziegenfuss T., Landis J., Hofheins J. Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to and peak force production during, resitance exercise. J. Int. Soc. Sports Nutr. 2008, 5:P15.